Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | NPC1 | O15118 | 3/20 | 0.70 |
| ▸ | RAB9A | P51151 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | TP53 | P04637 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4859450 | 0.83 | MAP4K4 (0.56) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL15614090 | 0.82 | MAP4K4 (0.59) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL19742855 | 0.82 | RAB9A (1.00) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL5321375 | 0.80 | MAP4K4 (0.67) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1198596 | 0.80 | NPC1 (0.55) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL12193535 | 0.80 | MAPT (0.52) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL9613271 | 0.80 | LMNA (0.52) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL1951940 | 0.80 | MAPT (0.52) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL12869440 | 0.80 | MAPT (0.47) | MAPTMEN1KMT2ANPC1RAB9A | |
| SCHEMBL398019 | 0.79 | MAP4K4 (0.61) | MAPTMEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120132069-A | Medical polyimide catheter with developing function and preparation method and application thereof | 宁波琳盛高分子材料有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-118852621-A | Polyimide compound, medical polyimide catheter, and preparation methods and applications thereof | 宁波琳盛高分子材料有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118846246-A | Medical polyimide catheter and preparation method and application thereof | 宁波琳盛高分子材料有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-103305961-A | Production method of polyimide and carbon nanotube composite fibers | CHANGCHUN APPLIED CHEMISTRY | 2013-09-18 | — | — | CN | claimed |
| CN-1733736-A | Nitrogenous fragrant heterocyclic diamine and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY (CN) | 2006-02-15 | — | — | CN | claimed |
| CN-120132069-A | Medical polyimide catheter with developing function and preparation method and application thereof | 宁波琳盛高分子材料有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-118852621-A | Polyimide compound, medical polyimide catheter, and preparation methods and applications thereof | 宁波琳盛高分子材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118846246-A | Medical polyimide catheter and preparation method and application thereof | 宁波琳盛高分子材料有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-113999527-B | Resin composition, composite resin, preparation and application thereof | 广东粤港澳大湾区黄埔材料研究院 | 2023-07-18 | — | — | CN | disclosed |
| CN-113999527-A | Resin composition, composite resin, and preparation and application thereof | 广东粤港澳大湾区黄埔材料研究院 | 2022-02-01 | — | — | CN | disclosed |
| CN-105671671-B | Preparation method of polyimide fiber containing symmetric bipyrimidine structure | 东华大学 | 2018-08-03 | — | — | CN | disclosed |
| CN-103305961-B | A kind of preparation method of polyimides-carbon nano tube composite fibre | 中国科学院长春应用化学研究所 | 2016-07-06 | — | — | CN | disclosed |
| US-20130035326-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2013-02-07 | — | — | US | disclosed |
| EP-2467137-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | Ambit Biosciences Corporation (US) | 2012-06-27 | — | — | EP | disclosed |
| CN-102470127-A | Biaryl compounds and methods of use thereof | AMBIT BIOSCIENCES CORP | 2012-05-23 | — | — | CN | disclosed |
| EP-1966151-B1 | POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS | SCHERING CORP (US) | 2011-10-05 | — | — | EP | disclosed |
| WO-2011022473-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2011-02-24 | — | — | WO | disclosed |
| EP-1984331-B1 | PYRROLIDINE DERIVATIVES AS ERK INHIBITORS | SCHERING CORP (US) | 2010-10-20 | — | — | EP | disclosed |
| CN-1733736-A | Nitrogenous fragrant heterocyclic diamine and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY (CN) | 2006-02-15 | — | — | CN | disclosed |
| CN-1733736-A | Nitrogenous fragrant heterocyclic diamine and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY (CN) | 2006-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035326-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | FLT3, CSF3R, CSF1R | MAPT 3602/4885MEN1 1373/4885KMT2A 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.